You have 9 free searches left this month | for more free features.

Macular Degeneration

Showing 1 - 25 of 3,601

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Neovascular Age-related Macular Degeneration Trial (RRG001)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • (no location specified)
Nov 15, 2023

Neovascular Age-related Macular Degeneration Trial in Graz (Aflibercept 40 MG/ML, Faricimab 120 MG/ML)

Recruiting
  • Neovascular Age-related Macular Degeneration
  • Aflibercept 40 MG/ML
  • Faricimab 120 MG/ML
  • Graz, Styria, Austria
    Department of Ophthalmolgy, Medical University Graz
Jul 3, 2023

Single Injection of Faricimab for nAMD With Persisting Fluid

Active, not recruiting
  • Neovascular Age-related Macular Degeneration
  • Glostrup, Denmark
    Miklos Schneider
Nov 3, 2023

Preparation of Patient Autologous Induced Pluripotent Stem

Not yet recruiting
  • Age-Related Macular Degeneration
  • somatic cell collection
  • (no location specified)
Aug 14, 2023

Diabetic Macular Edema (DME), Neovascular Age-Related Macular Degeneration (nAMD) Trial (aflibercept 8 mg PFS)

Not yet recruiting
  • Diabetic Macular Edema (DME)
  • Neovascular Age-Related Macular Degeneration (nAMD)
  • aflibercept 8 mg PFS
  • (no location specified)
Aug 3, 2023

Neovascular Age-related Macular Degeneration Trial in Phoenix (CLS-AX, Aflibercept)

Recruiting
  • Neovascular Age-related Macular Degeneration
  • Phoenix, Arizona
    Retinal Research Institute, LLC
Jun 4, 2023

Neovascular Age-related Macular Degeneration Trial in Suzhou (Aflibercept Ophthalmic, IBI302)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • Aflibercept Ophthalmic
  • IBI302
  • Suzhou, Jiangsu, China
    Innovent Biologics (Suzhou) Co,Ltd.
Jul 25, 2023

Neovascular Age-related Macular Degeneration Trial (PMC-403)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • (no location specified)
Jul 11, 2023

Age-related Wet Macular Degeneration Trial in United States (CG-P5 peptide, Placebo, Aflibercept Injection [Eylea])

Not yet recruiting
  • Age-related Wet Macular Degeneration
  • CG-P5 peptide
  • +2 more
  • Augusta, Georgia
  • +3 more
Nov 13, 2023

Age-Related Macular Degeneration Trial in Sydney, Melbourne, Tel Aviv (VOY-101)

Recruiting
  • Age-Related Macular Degeneration
  • VOY-101
  • Sydney, New South Wales, Australia
  • +3 more
Oct 17, 2023

Impact of Non-Exudative Type 1 MNV on AMD Progression

Recruiting
  • Age-Related Macular Degeneration
  • Neovascularization, Choroidal
    • Salt Lake City, Utah
      University of Utah
    Nov 15, 2023

    Age-Related Macular Degeneration Trial in Toronto (NG101 AAV gene therapy)

    Not yet recruiting
    • Age-Related Macular Degeneration
    • NG101 AAV gene therapy
    • Toronto, Ontario, Canada
      Vitreous Retina Macula Specialists of Toronto
    Aug 2, 2023

    Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in Beijing (Intravitreal injection of IBI302(dose 1),

    Suspended
    • Neovascular Age-related Macular Degeneration
    • Diabetic Macular Edema
    • Intravitreal injection of IBI302(dose 1)
    • +3 more
    • Beijing, Beijing, China
      Peking University People's Hospital
    Jul 17, 2023

    Intestinal Microbiome in Wet Age-related Macular Degeneration

    Recruiting
    • Age-Related Macular Degeneration
    • Sample examination
    • Io├ínnina, Epirus, Greece
    • +1 more
    Feb 23, 2023

    Neovascular Age-related Macular Degeneration Trial (AXT107 Low Dose, AXT107 Mid Dose, AXT107 High Dose)

    Not yet recruiting
    • Neovascular Age-related Macular Degeneration
    • AXT107 Low Dose
    • +2 more
    • (no location specified)
    May 5, 2023

    Rehabilitating Vision Loss in Veterans With Age-Related Macular

    Not yet recruiting
    • Age-related Macular Degeneration (AMD)
    • Study-specific rehabilitation (SSR) procedures
    • Augusta, Georgia
      Charlie Norwood VA Medical Center, Augusta, GA
    Mar 10, 2023

    Progression of Early Atrophic Lesions

    Not yet recruiting
    • Age-Related Macular Degeneration
    • No intervention
    • Salt Lake City, Utah
      University of Utah
    Jul 26, 2023

    Neovascular Age-related Macular Degeneration (nAMD) Trial in Abilene (OCU-10-C-110 for Injection)

    Not yet recruiting
    • Neovascular Age-related Macular Degeneration (nAMD)
    • OCU-10-C-110 for Injection
    • Abilene, Texas
      Retina Research Institute of Texas
    Jun 6, 2023

    Age-Related Macular Degeneration, Nonexudative Age-related Macular Degeneration Trial (Active microcurrent therapy)

    Completed
    • Age-Related Macular Degeneration
    • Nonexudative Age-related Macular Degeneration
    • Active microcurrent therapy
    • (no location specified)
    Jan 28, 2023

    Age-Related Macular Degeneration Trial in Worldwide (Yellow and red light emitting diode photobiomodulation (Eye Light,

    Recruiting
    • Age-Related Macular Degeneration
    • Yellow and red light emitting diode photobiomodulation (Eye Light, Espansione Group, Bologna, Italy)
    • Sham Mask
    • Paris, France
    • +6 more
    Sep 14, 2023

    Neovascular Age-related Macular Degeneration (nAMD) Trial (AR-14034 SR implant lower dose, Aflibercept Injection, Sham

    Not yet recruiting
    • Neovascular Age-related Macular Degeneration (nAMD)
    • AR-14034 SR implant lower dose
    • +3 more
    • (no location specified)
    Mar 3, 2023

    Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in Austin (AIV007)

    Not yet recruiting
    • Neovascular Age-related Macular Degeneration
    • Diabetic Macular Edema
    • Austin, Texas
      Retina Consultants of Austin
    Jan 16, 2023

    Neovascular Age-related Macular Degeneration Trial in Shanghai (LX102-C01 Injection)

    Active, not recruiting
    • Neovascular Age-related Macular Degeneration
    • LX102-C01 Injection
    • Shanghai, China
      Shanghai General Hospital, Shanghai Jiao Tong University School
    Apr 14, 2023

    Neovascular Age-related Macular Degeneration Trial in Katy, Norfolk (SKG0106)

    Not yet recruiting
    • Neovascular Age-related Macular Degeneration
    • SKG0106
    • Katy, Texas
    • +1 more
    Aug 15, 2023

    Neovascular Age-related Macular Degeneration (NVAMD), Diabetic Macular Edema (DME) Trial in United States (EYE103)

    Recruiting
    • Neovascular Age-related Macular Degeneration (NVAMD)
    • Diabetic Macular Edema (DME)
    • Phoenix, Arizona
    • +4 more
    Jun 14, 2023